{"text": "This report details Patient Z0, a patient with abnormal findings on diffusion-weighted imaging. Further investigation showed a progressive slowness of movement and a reduction in complex IV activity. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 94, "label": "HPO_TERM"}, {"start": 125, "end": 159, "label": "HPO_TERM"}, {"start": 164, "end": 198, "label": "HPO_TERM"}, {"start": 223, "end": 227, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z1, who has a history of elevated ALT enzymatic activity. Examination also revealed a partial deficiency of complex I. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 86, "label": "HPO_TERM"}, {"start": 114, "end": 147, "label": "HPO_TERM"}, {"start": 202, "end": 206, "label": "GENE_VARIANT"}]}
{"text": "Patient Z2 was evaluated for impaired function of mitochondrial complex I. The patient also presented with impaired function of mitochondrial complex IV and reduced mitochondrial DNA content in muscle. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 72, "label": "HPO_TERM"}, {"start": 106, "end": 149, "label": "HPO_TERM"}, {"start": 154, "end": 196, "label": "HPO_TERM"}, {"start": 227, "end": 231, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z3, a patient with a defect in mitochondrial complex I. Further investigation showed abnormal findings on diffusion-weighted imaging and slowness of movement. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 81, "label": "HPO_TERM"}, {"start": 112, "end": 159, "label": "HPO_TERM"}, {"start": 164, "end": 183, "label": "HPO_TERM"}, {"start": 207, "end": 211, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z4 were a severe reduction of mtDNA in muscle and abnormal morphology of the cerebral cortex. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 82, "label": "HPO_TERM"}, {"start": 87, "end": 128, "label": "HPO_TERM"}, {"start": 154, "end": 158, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z5 were a reduction in complex I activity and slowness of movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 76, "label": "HPO_TERM"}, {"start": 81, "end": 100, "label": "HPO_TERM"}, {"start": 126, "end": 130, "label": "GENE_VARIANT"}]}
{"text": "Patient Z6 was evaluated for elevated alanine aminotransferase. The patient also presented with abnormal DWI signal on brain MRI and a defect in mitochondrial complex I. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 62, "label": "HPO_TERM"}, {"start": 96, "end": 127, "label": "HPO_TERM"}, {"start": 132, "end": 166, "label": "HPO_TERM"}, {"start": 197, "end": 201, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z7 were slowness of movement and a defect in mitochondrial complex I. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 62, "label": "HPO_TERM"}, {"start": 67, "end": 101, "label": "HPO_TERM"}, {"start": 127, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "Patient Z8 was evaluated for slowness of movement. The patient also presented with low complex I enzymatic activity and a decrease in mitochondrial DNA in the muscles. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 48, "label": "HPO_TERM"}, {"start": 82, "end": 112, "label": "HPO_TERM"}, {"start": 117, "end": 164, "label": "HPO_TERM"}, {"start": 195, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z9, a patient with a congenital malformation of the cerebral cortex. Further investigation showed a rise in AST concentration and a partial deficiency of complex I. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 96, "label": "HPO_TERM"}, {"start": 127, "end": 153, "label": "HPO_TERM"}, {"start": 158, "end": 191, "label": "HPO_TERM"}, {"start": 215, "end": 219, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z10 includes an increase in the serum level of alanine aminotransferase and a severe reduction of mtDNA in muscle. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 109, "label": "HPO_TERM"}, {"start": 114, "end": 153, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z11 were a defect in mitochondrial complex I and areas of restricted diffusion on brain DWI. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 78, "label": "HPO_TERM"}, {"start": 83, "end": 126, "label": "HPO_TERM"}, {"start": 152, "end": 156, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z12 includes a severe reduction of mtDNA in muscle and a defect in mitochondrial complex I. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 124, "label": "HPO_TERM"}, {"start": 150, "end": 154, "label": "GENE_VARIANT"}]}
{"text": "Patient Z13 was evaluated for slowness of movement. The patient also presented with bradykinesia and high levels of alanine aminotransferase. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 95, "label": "HPO_TERM"}, {"start": 100, "end": 139, "label": "HPO_TERM"}, {"start": 170, "end": 174, "label": "GENE_VARIANT"}]}
{"text": "Patient Z14 was evaluated for multiple deletions in the mitochondrial DNA. The patient also presented with an accumulation of multiple mtDNA deletions and a defect in mitochondrial complex I. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 71, "label": "HPO_TERM"}, {"start": 105, "end": 146, "label": "HPO_TERM"}, {"start": 151, "end": 185, "label": "HPO_TERM"}, {"start": 216, "end": 220, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z15 were a decrease in mitochondrial DNA in the muscles and slowness of movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 91, "label": "HPO_TERM"}, {"start": 96, "end": 115, "label": "HPO_TERM"}, {"start": 141, "end": 145, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z16 includes low levels of mitochondrial DNA in muscle and bradykinesia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 89, "label": "HPO_TERM"}, {"start": 94, "end": 106, "label": "HPO_TERM"}, {"start": 132, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "Patient Z17 was evaluated for a low copy number of mtDNA in muscle tissue. The patient also presented with abnormal DWI signal on brain MRI and a partial deficiency of complex I. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 72, "label": "HPO_TERM"}, {"start": 106, "end": 137, "label": "HPO_TERM"}, {"start": 142, "end": 175, "label": "HPO_TERM"}, {"start": 206, "end": 210, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z18, who has a history of deficient cytochrome c oxidase activity. Examination also revealed bradykinesia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 134, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "Patient Z19 was evaluated for an increase in the serum level of alanine aminotransferase. The patient also presented with areas of restricted diffusion on brain DWI and a rise in AST concentration. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 89, "label": "HPO_TERM"}, {"start": 123, "end": 166, "label": "HPO_TERM"}, {"start": 171, "end": 197, "label": "HPO_TERM"}, {"start": 228, "end": 232, "label": "GENE_VARIANT"}]}
{"text": "Patient Z20 was evaluated for elevated alanine aminotransferase. The patient also presented with bradykinesia and slowness of movement. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 63, "label": "HPO_TERM"}, {"start": 97, "end": 109, "label": "HPO_TERM"}, {"start": 114, "end": 133, "label": "HPO_TERM"}, {"start": 164, "end": 168, "label": "GENE_VARIANT"}]}
{"text": "Patient Z21 was evaluated for a rise in AST concentration. The patient also presented with a partial deficiency of complex I and a defect in mitochondrial complex I. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 162, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z22, a patient with a reduction in complex IV activity. Further investigation showed slowness of movement and an increase in CSF lactate. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 82, "label": "HPO_TERM"}, {"start": 113, "end": 132, "label": "HPO_TERM"}, {"start": 137, "end": 159, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z23 includes high levels of alanine aminotransferase and bradykinesia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 102, "label": "HPO_TERM"}, {"start": 128, "end": 132, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z24 includes a defect in mitochondrial complex I and a progressive slowness of movement. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 80, "label": "HPO_TERM"}, {"start": 85, "end": 119, "label": "HPO_TERM"}, {"start": 145, "end": 149, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z25, who has a history of high levels of aspartate aminotransferase. Examination also revealed a low copy number of mtDNA in muscle tissue. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 95, "label": "HPO_TERM"}, {"start": 123, "end": 165, "label": "HPO_TERM"}, {"start": 220, "end": 224, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z26 includes a low copy number of mtDNA in muscle tissue and low complex I enzymatic activity. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 88, "label": "HPO_TERM"}, {"start": 93, "end": 123, "label": "HPO_TERM"}, {"start": 149, "end": 153, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z27 includes an accumulation of multiple mtDNA deletions and a partial deficiency of complex I. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 87, "label": "HPO_TERM"}, {"start": 92, "end": 125, "label": "HPO_TERM"}, {"start": 151, "end": 155, "label": "GENE_VARIANT"}]}
{"text": "Patient Z28 was evaluated for slowness of movement. The patient also presented with a quantitative defect of mitochondrial DNA in muscle and high levels of alanine aminotransferase. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 133, "label": "HPO_TERM"}, {"start": 138, "end": 177, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z29, who has a history of high ALT levels. Examination also revealed a rise in AST concentration. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 69, "label": "HPO_TERM"}, {"start": 97, "end": 123, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "Patient Z30 was evaluated for a severe reduction of mtDNA in muscle. The patient also presented with a rise in AST concentration and areas of restricted diffusion on brain DWI. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 69, "label": "HPO_TERM"}, {"start": 103, "end": 129, "label": "HPO_TERM"}, {"start": 134, "end": 177, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "Patient Z31 was evaluated for a defect in mitochondrial complex I. The patient also presented with a partial deficiency of complex I and an accumulation of multiple mtDNA deletions. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 64, "label": "HPO_TERM"}, {"start": 98, "end": 131, "label": "HPO_TERM"}, {"start": 136, "end": 177, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z32 were a quantitative defect of mitochondrial DNA in muscle and a progressive slowness of movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 94, "label": "HPO_TERM"}, {"start": 99, "end": 133, "label": "HPO_TERM"}, {"start": 159, "end": 163, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z33 were a severe reduction of mtDNA in muscle and an increase in CSF lactate. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 83, "label": "HPO_TERM"}, {"start": 88, "end": 110, "label": "HPO_TERM"}, {"start": 136, "end": 140, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z34 were a partial deficiency of complex I and a reduction in complex I activity. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 77, "label": "HPO_TERM"}, {"start": 82, "end": 115, "label": "HPO_TERM"}, {"start": 141, "end": 145, "label": "GENE_VARIANT"}]}
{"text": "Patient Z35 was evaluated for a general slowing of physical movements. The patient also presented with a reduction in complex I activity and multiple deletions in the mitochondrial DNA. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 68, "label": "HPO_TERM"}, {"start": 102, "end": 135, "label": "HPO_TERM"}, {"start": 140, "end": 181, "label": "HPO_TERM"}, {"start": 212, "end": 216, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z36, a patient with bradykinesia. Further investigation showed a reduction in complex I activity and a decrease in mitochondrial DNA in the muscles. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 60, "label": "HPO_TERM"}, {"start": 91, "end": 124, "label": "HPO_TERM"}, {"start": 129, "end": 176, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z37, a patient with elevated aspartate aminotransferase. Further investigation showed a quantitative defect of mitochondrial DNA in muscle and elevated lactate in CSF. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 83, "label": "HPO_TERM"}, {"start": 114, "end": 164, "label": "HPO_TERM"}, {"start": 169, "end": 190, "label": "HPO_TERM"}, {"start": 214, "end": 218, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z38, a patient with a severe reduction of mtDNA in muscle. Further investigation showed an abnormal thalamic MRI signal and an elevated circulating aspartate aminotransferase concentration. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 87, "label": "HPO_TERM"}, {"start": 118, "end": 147, "label": "HPO_TERM"}, {"start": 152, "end": 211, "label": "HPO_TERM"}, {"start": 235, "end": 239, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z39, who has a history of an abnormal thalamic MRI signal. Examination also revealed slowness of movement. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 85, "label": "HPO_TERM"}, {"start": 113, "end": 132, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "Patient Z40 was evaluated for slowness of movement. The patient also presented with areas of restricted diffusion on brain DWI and an increase in CSF lactate. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 126, "label": "HPO_TERM"}, {"start": 131, "end": 153, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z41 includes a congenital malformation of the cerebral cortex and high levels of aspartate aminotransferase. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 95, "label": "HPO_TERM"}, {"start": 100, "end": 139, "label": "HPO_TERM"}, {"start": 165, "end": 169, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z42, a patient with abnormally high ALT levels. Further investigation showed complex I deficiency and slowness of movement. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 72, "label": "HPO_TERM"}, {"start": 103, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 146, "label": "HPO_TERM"}, {"start": 170, "end": 174, "label": "GENE_VARIANT"}]}
{"text": "Patient Z43 was evaluated for multiple deletions in the mitochondrial DNA. The patient also presented with a reduction in complex IV activity and high levels of alanine aminotransferase. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 71, "label": "HPO_TERM"}, {"start": 105, "end": 139, "label": "HPO_TERM"}, {"start": 144, "end": 183, "label": "HPO_TERM"}, {"start": 214, "end": 218, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z44 includes a defect in mitochondrial complex I and a reduction in complex I activity. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 80, "label": "HPO_TERM"}, {"start": 85, "end": 118, "label": "HPO_TERM"}, {"start": 144, "end": 148, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z45 were a rise in AST concentration and a severe reduction of mtDNA in muscle. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 70, "label": "HPO_TERM"}, {"start": 75, "end": 114, "label": "HPO_TERM"}, {"start": 140, "end": 144, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z46, a patient with a history of reduced mitochondrial DNA content in muscle. Examination also revealed slowness of movement. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 98, "label": "HPO_TERM"}, {"start": 126, "end": 145, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "Patient Z47 was evaluated for a low copy number of mtDNA in muscle tissue. The patient also presented with slowness of movement and abnormal cortical architecture. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 72, "label": "HPO_TERM"}, {"start": 106, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 159, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z48 were a partial deficiency of complex I and an elevated CSF lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 77, "label": "HPO_TERM"}, {"start": 82, "end": 107, "label": "HPO_TERM"}, {"start": 133, "end": 137, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z49 were an abnormal thalamic MRI signal and multiple mitochondrial DNA deletions. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 73, "label": "HPO_TERM"}, {"start": 78, "end": 113, "label": "HPO_TERM"}, {"start": 139, "end": 143, "label": "GENE_VARIANT"}]}
{"text": "Patient Z50 was evaluated for abnormal findings on diffusion-weighted imaging. The patient also presented with bradykinesia and high AST levels. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 77, "label": "HPO_TERM"}, {"start": 111, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 142, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z51, who has a history of slowness of movement. Examination also revealed areas of restricted diffusion on brain DWI. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 75, "label": "HPO_TERM"}, {"start": 103, "end": 146, "label": "HPO_TERM"}, {"start": 201, "end": 205, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z52, a patient with slowness of movement. Further investigation showed a low copy number of mtDNA in muscle tissue and a defect in mitochondrial complex I. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 67, "label": "HPO_TERM"}, {"start": 98, "end": 140, "label": "HPO_TERM"}, {"start": 145, "end": 179, "label": "HPO_TERM"}, {"start": 203, "end": 207, "label": "GENE_VARIANT"}]}
{"text": "Patient Z53 was evaluated for slowness of movement. The patient also presented with a congenital malformation of the cerebral cortex and an elevated CSF lactate level. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 132, "label": "HPO_TERM"}, {"start": 137, "end": 162, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z54 were an accumulation of multiple mtDNA deletions and a partial deficiency of complex I. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 123, "label": "HPO_TERM"}, {"start": 149, "end": 153, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z55, a patient with high levels of aspartate aminotransferase. Further investigation showed bradykinesia and an elevated CSF lactate level. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 87, "label": "HPO_TERM"}, {"start": 118, "end": 130, "label": "HPO_TERM"}, {"start": 135, "end": 160, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "Patient Z56 was evaluated for a low copy number of mtDNA in muscle tissue. The patient also presented with an elevated circulating aspartate aminotransferase concentration and slowness of movement. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 72, "label": "HPO_TERM"}, {"start": 106, "end": 165, "label": "HPO_TERM"}, {"start": 170, "end": 189, "label": "HPO_TERM"}, {"start": 220, "end": 224, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z57 were a structural malformation of the brain's outer layer and high ALT levels. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 96, "label": "HPO_TERM"}, {"start": 101, "end": 114, "label": "HPO_TERM"}, {"start": 140, "end": 144, "label": "GENE_VARIANT"}]}
{"text": "Patient Z58 was evaluated for high AST levels. The patient also presented with an accumulation of multiple mtDNA deletions and a rise in AST concentration. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 44, "label": "HPO_TERM"}, {"start": 78, "end": 119, "label": "HPO_TERM"}, {"start": 124, "end": 150, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z59 were an increase in the serum level of aspartate aminotransferase and bradykinesia. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 103, "label": "HPO_TERM"}, {"start": 108, "end": 120, "label": "HPO_TERM"}, {"start": 146, "end": 150, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z60, a patient with an accumulation of multiple mtDNA deletions. Further investigation showed high levels of alanine aminotransferase and an elevated CSF lactate level. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 89, "label": "HPO_TERM"}, {"start": 120, "end": 159, "label": "HPO_TERM"}, {"start": 164, "end": 189, "label": "HPO_TERM"}, {"start": 213, "end": 217, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z61 includes multiple deletions in the mitochondrial DNA and a severe reduction of mtDNA in muscle. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 87, "label": "HPO_TERM"}, {"start": 92, "end": 131, "label": "HPO_TERM"}, {"start": 157, "end": 161, "label": "GENE_VARIANT"}]}
{"text": "Patient Z62 was evaluated for an accumulation of multiple mtDNA deletions. The patient also presented with an elevated circulating aspartate aminotransferase concentration and a quantitative defect of mitochondrial DNA in muscle. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 71, "label": "HPO_TERM"}, {"start": 105, "end": 164, "label": "HPO_TERM"}, {"start": 169, "end": 219, "label": "HPO_TERM"}, {"start": 250, "end": 254, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z63 includes a reduction in complex I activity and slowness of movement. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 79, "label": "HPO_TERM"}, {"start": 84, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z64, a patient with a partial deficiency of complex I. Further investigation showed a reduction in complex IV activity and slowness of movement. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 81, "label": "HPO_TERM"}, {"start": 112, "end": 146, "label": "HPO_TERM"}, {"start": 151, "end": 170, "label": "HPO_TERM"}, {"start": 194, "end": 198, "label": "GENE_VARIANT"}]}
{"text": "Patient Z65 was evaluated for an increase in CSF lactate. The patient also presented with complex I deficiency and multiple mitochondrial DNA deletions. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 52, "label": "HPO_TERM"}, {"start": 86, "end": 105, "label": "HPO_TERM"}, {"start": 110, "end": 145, "label": "HPO_TERM"}, {"start": 176, "end": 180, "label": "GENE_VARIANT"}]}
{"text": "Patient Z66 was evaluated for a congenital malformation of the cerebral cortex. The patient also presented with a partial deficiency of complex I and a defect in mitochondrial complex I. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 79, "label": "HPO_TERM"}, {"start": 113, "end": 146, "label": "HPO_TERM"}, {"start": 151, "end": 185, "label": "HPO_TERM"}, {"start": 216, "end": 220, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z67, a patient with elevated ALT enzymatic activity. Further investigation showed a partial deficiency of complex I and deficient cytochrome c oxidase activity. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 79, "label": "HPO_TERM"}, {"start": 110, "end": 143, "label": "HPO_TERM"}, {"start": 148, "end": 186, "label": "HPO_TERM"}, {"start": 210, "end": 214, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z68 were high ALT levels and a partial deficiency of complex I. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 58, "label": "HPO_TERM"}, {"start": 63, "end": 96, "label": "HPO_TERM"}, {"start": 122, "end": 126, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z69 were a low copy number of mtDNA in muscle tissue and low complex I enzymatic activity. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 86, "label": "HPO_TERM"}, {"start": 91, "end": 121, "label": "HPO_TERM"}, {"start": 147, "end": 151, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z70 were an abnormal thalamic MRI signal and an elevated CSF lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 73, "label": "HPO_TERM"}, {"start": 78, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z71, a patient with complex I deficiency. Further investigation showed a partial deficiency of complex I and an elevated CSF lactate level. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 67, "label": "HPO_TERM"}, {"start": 98, "end": 131, "label": "HPO_TERM"}, {"start": 136, "end": 161, "label": "HPO_TERM"}, {"start": 185, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z72, who has a history of slowness of movement. Examination also revealed low complex I enzymatic activity. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 75, "label": "HPO_TERM"}, {"start": 103, "end": 133, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z73 includes a reduction in complex I activity and slowness of movement. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 79, "label": "HPO_TERM"}, {"start": 84, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z74 were an elevated CSF lactate level and cytochrome c oxidase deficiency. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 104, "label": "HPO_TERM"}, {"start": 130, "end": 134, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z75 were an abnormal thalamic MRI signal and an accumulation of multiple mtDNA deletions. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 73, "label": "HPO_TERM"}, {"start": 78, "end": 119, "label": "HPO_TERM"}, {"start": 145, "end": 149, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z76 includes increased ALT in the blood and high ALT levels. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 88, "label": "HPO_TERM"}, {"start": 114, "end": 118, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z77 includes the presence of multiple mtDNA deletions and a reduction in complex IV activity. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 124, "label": "HPO_TERM"}, {"start": 150, "end": 154, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z78, who has a history of an abnormal thalamic MRI signal. Examination also revealed complex I deficiency. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 85, "label": "HPO_TERM"}, {"start": 113, "end": 132, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "Patient Z79 was evaluated for reduced mitochondrial DNA content in muscle. The patient also presented with areas of restricted diffusion on brain DWI and a rise in AST concentration. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 72, "label": "HPO_TERM"}, {"start": 106, "end": 149, "label": "HPO_TERM"}, {"start": 154, "end": 180, "label": "HPO_TERM"}, {"start": 211, "end": 215, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z80 were a decrease in mitochondrial DNA in the muscles and a defect in mitochondrial complex I. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 91, "label": "HPO_TERM"}, {"start": 96, "end": 130, "label": "HPO_TERM"}, {"start": 156, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z81, who has a history of an elevated CSF lactate level. Examination also revealed difficulty initiating movement. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 81, "label": "HPO_TERM"}, {"start": 109, "end": 137, "label": "HPO_TERM"}, {"start": 192, "end": 196, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z82 were a progressive slowness of movement and an abnormal thalamic MRI signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 78, "label": "HPO_TERM"}, {"start": 83, "end": 112, "label": "HPO_TERM"}, {"start": 138, "end": 142, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z83, who has a history of a decrease in mitochondrial DNA in the muscles. Examination also revealed slowness of movement. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 103, "label": "HPO_TERM"}, {"start": 131, "end": 150, "label": "HPO_TERM"}, {"start": 205, "end": 209, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z84, a patient with a defect in mitochondrial complex I. Further investigation showed slowness of movement and an accumulation of multiple mtDNA deletions. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 82, "label": "HPO_TERM"}, {"start": 113, "end": 132, "label": "HPO_TERM"}, {"start": 137, "end": 178, "label": "HPO_TERM"}, {"start": 202, "end": 206, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z85, a patient with a quantitative defect of mitochondrial DNA in muscle. Further investigation showed a rise in AST concentration and a low copy number of mtDNA in muscle tissue. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 98, "label": "HPO_TERM"}, {"start": 129, "end": 155, "label": "HPO_TERM"}, {"start": 160, "end": 202, "label": "HPO_TERM"}, {"start": 226, "end": 230, "label": "GENE_VARIANT"}]}
{"text": "Patient Z86 was evaluated for an increase in CSF lactate. The patient also presented with complex I deficiency and a severe reduction of mtDNA in muscle. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 52, "label": "HPO_TERM"}, {"start": 86, "end": 105, "label": "HPO_TERM"}, {"start": 110, "end": 149, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z87, a patient with a progressive slowness of movement. Further investigation showed complex I deficiency and an increase in CSF lactate. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 82, "label": "HPO_TERM"}, {"start": 113, "end": 132, "label": "HPO_TERM"}, {"start": 137, "end": 159, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z88 includes the occurrence of multiple mtDNA deletions and a defect in mitochondrial complex I. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 86, "label": "HPO_TERM"}, {"start": 91, "end": 125, "label": "HPO_TERM"}, {"start": 151, "end": 155, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z89 were an elevated CSF lactate level and an abnormal thalamic MRI signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z90 were an elevated CSF lactate level and bradykinesia. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "Patient Z91 was evaluated for a severe reduction of mtDNA in muscle. The patient also presented with an elevated circulating aspartate aminotransferase concentration and slowness of movement. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 69, "label": "HPO_TERM"}, {"start": 103, "end": 162, "label": "HPO_TERM"}, {"start": 167, "end": 186, "label": "HPO_TERM"}, {"start": 217, "end": 221, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z92, a patient with a reduction in complex IV activity. Further investigation showed a progressive slowness of movement and abnormal cortical architecture. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 82, "label": "HPO_TERM"}, {"start": 113, "end": 147, "label": "HPO_TERM"}, {"start": 152, "end": 180, "label": "HPO_TERM"}, {"start": 204, "end": 208, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z93 were a rise in AST concentration and a low copy number of mtDNA in muscle tissue. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 70, "label": "HPO_TERM"}, {"start": 75, "end": 117, "label": "HPO_TERM"}, {"start": 143, "end": 147, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z94 includes high AST levels and an elevated CSF lactate level. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 90, "label": "HPO_TERM"}, {"start": 116, "end": 120, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z95, who has a history of slowness of movement. Examination also revealed cytochrome c oxidase deficiency. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 75, "label": "HPO_TERM"}, {"start": 103, "end": 133, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z96, a patient with slowness of movement. Further investigation showed deficient cytochrome c oxidase activity and an accumulation of multiple mtDNA deletions. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 67, "label": "HPO_TERM"}, {"start": 98, "end": 136, "label": "HPO_TERM"}, {"start": 141, "end": 182, "label": "HPO_TERM"}, {"start": 206, "end": 210, "label": "GENE_VARIANT"}]}
{"text": "Patient Z97 was evaluated for increased CSF lactate. The patient also presented with a progressive slowness of movement and bradykinesia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 51, "label": "HPO_TERM"}, {"start": 85, "end": 119, "label": "HPO_TERM"}, {"start": 124, "end": 136, "label": "HPO_TERM"}, {"start": 167, "end": 171, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z98, a patient with an elevated CSF lactate level. Further investigation showed a progressive slowness of movement and complex I deficiency. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 138, "label": "HPO_TERM"}, {"start": 143, "end": 162, "label": "HPO_TERM"}, {"start": 186, "end": 190, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z99, a patient with bradykinesia. Further investigation showed a reduction in complex IV activity and high levels of alanine aminotransferase. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 60, "label": "HPO_TERM"}, {"start": 91, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 169, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "Patient Z100 was evaluated for slowness of movement. The patient also presented with a severe reduction of mtDNA in muscle and a defect in mitochondrial complex I. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 162, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z101 were high levels of alanine aminotransferase and bradykinesia. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 101, "label": "HPO_TERM"}, {"start": 127, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z102 were elevated ALT enzymatic activity and a decrease in mitochondrial DNA in the muscles. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 76, "label": "HPO_TERM"}, {"start": 81, "end": 128, "label": "HPO_TERM"}, {"start": 154, "end": 158, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z103, who has a history of an elevated CSF lactate level. Examination also revealed bradykinesia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 82, "label": "HPO_TERM"}, {"start": 110, "end": 122, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z104, who has a history of a reduction in complex I activity. Examination also revealed abnormal cortical architecture. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 90, "label": "HPO_TERM"}, {"start": 118, "end": 146, "label": "HPO_TERM"}, {"start": 201, "end": 205, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z105, a patient with reduced mitochondrial DNA content in muscle. Further investigation showed a partial deficiency of complex I and high AST levels. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 91, "label": "HPO_TERM"}, {"start": 122, "end": 155, "label": "HPO_TERM"}, {"start": 160, "end": 174, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "Patient Z106 was evaluated for abnormally high AST levels. The patient also presented with a defect in mitochondrial complex I and slowness of movement. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 147, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z107 were elevated aspartate aminotransferase and multiple mitochondrial DNA deletions. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 80, "label": "HPO_TERM"}, {"start": 85, "end": 120, "label": "HPO_TERM"}, {"start": 146, "end": 150, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z108, who has a history of high levels of alanine aminotransferase. Examination also revealed a decrease in mitochondrial DNA in the muscles. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 96, "label": "HPO_TERM"}, {"start": 124, "end": 171, "label": "HPO_TERM"}, {"start": 226, "end": 230, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z109 includes a decrease in mitochondrial DNA in the muscles and bradykinesia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 94, "label": "HPO_TERM"}, {"start": 99, "end": 111, "label": "HPO_TERM"}, {"start": 137, "end": 141, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z110 were elevated alanine aminotransferase and an elevated CSF lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 78, "label": "HPO_TERM"}, {"start": 83, "end": 108, "label": "HPO_TERM"}, {"start": 134, "end": 138, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z111 were abnormal findings on diffusion-weighted imaging and an elevated CSF lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 92, "label": "HPO_TERM"}, {"start": 97, "end": 122, "label": "HPO_TERM"}, {"start": 148, "end": 152, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z112, who has a history of a decrease in mitochondrial DNA in the muscles. Examination also revealed elevated lactate in CSF. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 104, "label": "HPO_TERM"}, {"start": 132, "end": 153, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z113, who has a history of an elevated CSF lactate level. Examination also revealed complex I deficiency. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 82, "label": "HPO_TERM"}, {"start": 110, "end": 129, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z114 were abnormal findings on diffusion-weighted imaging and slowness of movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 92, "label": "HPO_TERM"}, {"start": 97, "end": 116, "label": "HPO_TERM"}, {"start": 142, "end": 146, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z115, who has a history of a reduction in complex IV activity. Examination also revealed bradykinesia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 91, "label": "HPO_TERM"}, {"start": 119, "end": 131, "label": "HPO_TERM"}, {"start": 186, "end": 190, "label": "GENE_VARIANT"}]}
{"text": "Patient Z116 was evaluated for abnormally high AST levels. The patient also presented with multiple mitochondrial DNA deletions and complex I deficiency. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 124, "label": "HPO_TERM"}, {"start": 129, "end": 148, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z117, a patient with slowness of movement. Further investigation showed multiple mitochondrial DNA deletions and high AST levels. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 68, "label": "HPO_TERM"}, {"start": 99, "end": 134, "label": "HPO_TERM"}, {"start": 139, "end": 153, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z118 includes high levels of alanine aminotransferase and an elevated CSF lactate level. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 86, "label": "HPO_TERM"}, {"start": 91, "end": 116, "label": "HPO_TERM"}, {"start": 142, "end": 146, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z119, a patient with slowness of movement. Further investigation showed a low copy number of mtDNA in muscle tissue and a defect in mitochondrial complex I. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 68, "label": "HPO_TERM"}, {"start": 99, "end": 141, "label": "HPO_TERM"}, {"start": 146, "end": 180, "label": "HPO_TERM"}, {"start": 204, "end": 208, "label": "GENE_VARIANT"}]}
{"text": "Patient Z120 was evaluated for high levels of alanine aminotransferase. The patient also presented with areas of restricted diffusion on brain DWI and a reduction in complex IV activity. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 70, "label": "HPO_TERM"}, {"start": 104, "end": 147, "label": "HPO_TERM"}, {"start": 152, "end": 186, "label": "HPO_TERM"}, {"start": 217, "end": 221, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z121, a patient with abnormal findings on diffusion-weighted imaging. Further investigation showed slowness of movement and an elevated CSF lactate level. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 96, "label": "HPO_TERM"}, {"start": 127, "end": 146, "label": "HPO_TERM"}, {"start": 151, "end": 176, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z122 were complex I deficiency and an accumulation of multiple mtDNA deletions. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 110, "label": "HPO_TERM"}, {"start": 136, "end": 140, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z123, who has a history of a decrease in mitochondrial DNA in the muscles. Examination also revealed a low copy number of mtDNA in muscle tissue. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 104, "label": "HPO_TERM"}, {"start": 132, "end": 174, "label": "HPO_TERM"}, {"start": 229, "end": 233, "label": "GENE_VARIANT"}]}
{"text": "Patient Z124 was evaluated for multiple mitochondrial DNA deletions. The patient also presented with a defect in mitochondrial complex I and a reduction in complex IV activity. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 66, "label": "HPO_TERM"}, {"start": 100, "end": 134, "label": "HPO_TERM"}, {"start": 139, "end": 173, "label": "HPO_TERM"}, {"start": 204, "end": 208, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z125 were difficulty initiating movement and a reduction in complex IV activity. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 73, "label": "HPO_TERM"}, {"start": 78, "end": 112, "label": "HPO_TERM"}, {"start": 138, "end": 142, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z126 includes an elevated CSF lactate level and cytochrome c oxidase deficiency. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 72, "label": "HPO_TERM"}, {"start": 77, "end": 107, "label": "HPO_TERM"}, {"start": 133, "end": 137, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z127, a patient with abnormal cortical architecture. Further investigation showed a reduction in complex IV activity and an elevated CSF lactate level. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 77, "label": "HPO_TERM"}, {"start": 108, "end": 142, "label": "HPO_TERM"}, {"start": 147, "end": 172, "label": "HPO_TERM"}, {"start": 196, "end": 200, "label": "GENE_VARIANT"}]}
{"text": "Patient Z128 was evaluated for slowness of movement. The patient also presented with a reduction in complex IV activity and abnormal findings on diffusion-weighted imaging. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 170, "label": "HPO_TERM"}, {"start": 201, "end": 205, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z129 includes abnormally high AST levels and an elevated CSF lactate level. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 71, "label": "HPO_TERM"}, {"start": 76, "end": 101, "label": "HPO_TERM"}, {"start": 127, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z130, a patient with a congenital malformation of the cerebral cortex. Further investigation showed deficient cytochrome c oxidase activity and an elevated CSF lactate level. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 98, "label": "HPO_TERM"}, {"start": 129, "end": 167, "label": "HPO_TERM"}, {"start": 172, "end": 197, "label": "HPO_TERM"}, {"start": 221, "end": 225, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z131, a patient with high levels of aspartate aminotransferase. Further investigation showed a defect in mitochondrial complex I and increased CSF lactate. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 88, "label": "HPO_TERM"}, {"start": 119, "end": 153, "label": "HPO_TERM"}, {"start": 158, "end": 179, "label": "HPO_TERM"}, {"start": 203, "end": 207, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z132, who has a history of slowness of movement. Examination also revealed a reduction in complex IV activity. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 138, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "Patient Z133 was evaluated for an elevated CSF lactate level. The patient also presented with a partial deficiency of complex I and a defect in mitochondrial complex I. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 162, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "Patient Z134 was evaluated for high levels of alanine aminotransferase. The patient also presented with abnormal cortical architecture and elevated lactate in CSF. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 70, "label": "HPO_TERM"}, {"start": 104, "end": 132, "label": "HPO_TERM"}, {"start": 137, "end": 158, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z135, a patient with an increase in CSF lactate. Further investigation showed an elevated circulating aspartate aminotransferase concentration and slowness of movement. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 71, "label": "HPO_TERM"}, {"start": 102, "end": 161, "label": "HPO_TERM"}, {"start": 166, "end": 185, "label": "HPO_TERM"}, {"start": 209, "end": 213, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z136 were a partial deficiency of complex I and an elevated CSF lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 78, "label": "HPO_TERM"}, {"start": 83, "end": 108, "label": "HPO_TERM"}, {"start": 134, "end": 138, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z137, who has a history of an abnormal thalamic MRI signal. Examination also revealed complex I deficiency. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 86, "label": "HPO_TERM"}, {"start": 114, "end": 133, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z138 were abnormally high ALT levels and an elevated CSF lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 99, "label": "HPO_TERM"}, {"start": 125, "end": 129, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z139 includes an elevated CSF lactate level and an elevated circulating aspartate aminotransferase concentration. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 72, "label": "HPO_TERM"}, {"start": 77, "end": 136, "label": "HPO_TERM"}, {"start": 162, "end": 166, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z140 includes an elevated circulating aspartate aminotransferase concentration and slowness of movement. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 106, "label": "HPO_TERM"}, {"start": 111, "end": 130, "label": "HPO_TERM"}, {"start": 156, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z141 were a reduction in complex IV activity and slowness of movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 79, "label": "HPO_TERM"}, {"start": 84, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z142, a patient with a reduction in complex I activity. Further investigation showed a decrease in mitochondrial DNA in the muscles and slowness of movement. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 82, "label": "HPO_TERM"}, {"start": 113, "end": 160, "label": "HPO_TERM"}, {"start": 165, "end": 184, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z143, who has a history of slowness of movement. Examination also revealed elevated lactate in CSF. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 125, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z144, who has a history of an elevated CSF lactate level. Examination also revealed bradykinesia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 82, "label": "HPO_TERM"}, {"start": 110, "end": 122, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z145 were an elevated CSF lactate level and a decrease in mitochondrial DNA in the muscles. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 70, "label": "HPO_TERM"}, {"start": 75, "end": 122, "label": "HPO_TERM"}, {"start": 148, "end": 152, "label": "GENE_VARIANT"}]}
{"text": "Patient Z146 was evaluated for a severe reduction of mtDNA in muscle. The patient also presented with an elevated CSF lactate level and high levels of alanine aminotransferase. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 70, "label": "HPO_TERM"}, {"start": 104, "end": 129, "label": "HPO_TERM"}, {"start": 134, "end": 173, "label": "HPO_TERM"}, {"start": 204, "end": 208, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z147 were slowness of movement and multiple mitochondrial DNA deletions. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 104, "label": "HPO_TERM"}, {"start": 130, "end": 134, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z148 were abnormal cortical architecture and slowness of movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 73, "label": "HPO_TERM"}, {"start": 78, "end": 97, "label": "HPO_TERM"}, {"start": 123, "end": 127, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z149, a patient with a severe reduction of mtDNA in muscle. Further investigation showed multiple mitochondrial DNA deletions and high levels of alanine aminotransferase. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 88, "label": "HPO_TERM"}, {"start": 119, "end": 154, "label": "HPO_TERM"}, {"start": 159, "end": 198, "label": "HPO_TERM"}, {"start": 222, "end": 226, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z150 includes complex I deficiency and multiple mitochondrial DNA deletions. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 66, "label": "HPO_TERM"}, {"start": 71, "end": 106, "label": "HPO_TERM"}, {"start": 132, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "Patient Z151 was evaluated for a severe reduction of mtDNA in muscle. The patient also presented with an accumulation of multiple mtDNA deletions and slowness of movement. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 70, "label": "HPO_TERM"}, {"start": 104, "end": 145, "label": "HPO_TERM"}, {"start": 150, "end": 169, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z152, who has a history of slowness of movement. Examination also revealed abnormally high ALT levels. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 128, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z153 were a reduction in complex IV activity and an elevated CSF lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 79, "label": "HPO_TERM"}, {"start": 84, "end": 109, "label": "HPO_TERM"}, {"start": 135, "end": 139, "label": "GENE_VARIANT"}]}
{"text": "Patient Z154 was evaluated for a low copy number of mtDNA in muscle tissue. The patient also presented with slowness of movement and an elevated CSF lactate level. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 73, "label": "HPO_TERM"}, {"start": 107, "end": 126, "label": "HPO_TERM"}, {"start": 131, "end": 156, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z155 were increased ALT in the blood and slowness of movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 92, "label": "HPO_TERM"}, {"start": 118, "end": 122, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z156 includes reduced mitochondrial DNA content in muscle and an elevated CSF lactate level. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 89, "label": "HPO_TERM"}, {"start": 94, "end": 119, "label": "HPO_TERM"}, {"start": 145, "end": 149, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z157 were abnormally high AST levels and an elevated CSF lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 99, "label": "HPO_TERM"}, {"start": 125, "end": 129, "label": "GENE_VARIANT"}]}
{"text": "Patient Z158 was evaluated for slowness of movement. The patient also presented with a partial deficiency of complex I and a progressive slowness of movement. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 117, "label": "HPO_TERM"}, {"start": 122, "end": 156, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z159 includes a quantitative defect of mitochondrial DNA in muscle and bradykinesia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 97, "label": "HPO_TERM"}, {"start": 102, "end": 114, "label": "HPO_TERM"}, {"start": 140, "end": 144, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z160, a patient with a reduction in complex I activity. Further investigation showed a severe reduction of mtDNA in muscle and a quantitative defect of mitochondrial DNA in muscle. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 82, "label": "HPO_TERM"}, {"start": 113, "end": 152, "label": "HPO_TERM"}, {"start": 157, "end": 207, "label": "HPO_TERM"}, {"start": 231, "end": 235, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z161, who has a history of slowness of movement. Examination also revealed an elevated CSF lactate level. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 129, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z162, a patient with slowness of movement. Further investigation showed abnormally high AST levels and a quantitative defect of mitochondrial DNA in muscle. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 68, "label": "HPO_TERM"}, {"start": 99, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 178, "label": "HPO_TERM"}, {"start": 202, "end": 206, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z163, who has a history of an elevated CSF lactate level. Examination also revealed multiple mitochondrial DNA deletions. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 82, "label": "HPO_TERM"}, {"start": 110, "end": 145, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "Patient Z164 was evaluated for increased CSF lactate. The patient also presented with abnormally high ALT levels and multiple mitochondrial DNA deletions. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 52, "label": "HPO_TERM"}, {"start": 86, "end": 110, "label": "HPO_TERM"}, {"start": 115, "end": 150, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z165, a patient with mtDNA depletion in muscle. Further investigation showed an increase in CSF lactate and areas of restricted diffusion on brain DWI. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 126, "label": "HPO_TERM"}, {"start": 131, "end": 174, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z166, who has a history of deficient cytochrome c oxidase activity. Examination also revealed complex I deficiency. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 95, "label": "HPO_TERM"}, {"start": 123, "end": 142, "label": "HPO_TERM"}, {"start": 197, "end": 201, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z167, who has a history of complex I deficiency. Examination also revealed an elevated CSF lactate level. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 129, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z168 were slowness of movement and abnormal cortical architecture. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 97, "label": "HPO_TERM"}, {"start": 123, "end": 127, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z169, who has a history of a reduction in complex IV activity. Examination also revealed elevated ALT enzymatic activity. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 91, "label": "HPO_TERM"}, {"start": 119, "end": 150, "label": "HPO_TERM"}, {"start": 205, "end": 209, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z170 includes an increase in the serum level of aspartate aminotransferase and slowness of movement. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 106, "label": "HPO_TERM"}, {"start": 111, "end": 130, "label": "HPO_TERM"}, {"start": 156, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z171 were a partial deficiency of complex I and an accumulation of multiple mtDNA deletions. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 78, "label": "HPO_TERM"}, {"start": 83, "end": 124, "label": "HPO_TERM"}, {"start": 150, "end": 154, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z172 includes a defect in mitochondrial complex I and a reduction in complex IV activity. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 81, "label": "HPO_TERM"}, {"start": 86, "end": 120, "label": "HPO_TERM"}, {"start": 146, "end": 150, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z173 were bradykinesia and slowness of movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 57, "label": "HPO_TERM"}, {"start": 62, "end": 81, "label": "HPO_TERM"}, {"start": 107, "end": 111, "label": "GENE_VARIANT"}]}
{"text": "Patient Z174 was evaluated for a severe reduction of mtDNA in muscle. The patient also presented with abnormal cortical architecture and an elevated CSF lactate level. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 70, "label": "HPO_TERM"}, {"start": 104, "end": 132, "label": "HPO_TERM"}, {"start": 137, "end": 162, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "Patient Z175 was evaluated for multiple mitochondrial DNA deletions. The patient also presented with an elevated circulating aspartate aminotransferase concentration and a decrease in mitochondrial DNA in the muscles. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 66, "label": "HPO_TERM"}, {"start": 100, "end": 159, "label": "HPO_TERM"}, {"start": 164, "end": 211, "label": "HPO_TERM"}, {"start": 242, "end": 246, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z176, a patient with a reduction in complex I activity. Further investigation showed a rise in AST concentration and a partial deficiency of complex I. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 82, "label": "HPO_TERM"}, {"start": 113, "end": 139, "label": "HPO_TERM"}, {"start": 144, "end": 177, "label": "HPO_TERM"}, {"start": 201, "end": 205, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z177 includes a partial deficiency of complex I and an elevated CSF lactate level. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 80, "label": "HPO_TERM"}, {"start": 85, "end": 110, "label": "HPO_TERM"}, {"start": 136, "end": 140, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z178, who has a history of slowness of movement. Examination also revealed multiple mitochondrial DNA deletions. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 139, "label": "HPO_TERM"}, {"start": 194, "end": 198, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z179 were a severe reduction of mtDNA in muscle and a partial deficiency of complex I. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 122, "label": "HPO_TERM"}, {"start": 148, "end": 152, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z180 includes reduced mitochondrial DNA content in muscle and an elevated CSF lactate level. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 89, "label": "HPO_TERM"}, {"start": 94, "end": 119, "label": "HPO_TERM"}, {"start": 145, "end": 149, "label": "GENE_VARIANT"}]}
{"text": "Patient Z181 was evaluated for a severe reduction of mtDNA in muscle. The patient also presented with a partial deficiency of complex I and bradykinesia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 70, "label": "HPO_TERM"}, {"start": 104, "end": 137, "label": "HPO_TERM"}, {"start": 142, "end": 154, "label": "HPO_TERM"}, {"start": 185, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z182, who has a history of complex I deficiency. Examination also revealed an elevated CSF lactate level. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 129, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "Patient Z183 was evaluated for multiple mitochondrial DNA deletions. The patient also presented with abnormal cortical architecture and slowness of movement. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 66, "label": "HPO_TERM"}, {"start": 100, "end": 128, "label": "HPO_TERM"}, {"start": 133, "end": 152, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z184 were abnormally high ALT levels and an abnormal thalamic MRI signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "Patient Z185 was evaluated for a severe reduction of mtDNA in muscle. The patient also presented with a partial deficiency of complex I and a reduction in complex IV activity. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 70, "label": "HPO_TERM"}, {"start": 104, "end": 137, "label": "HPO_TERM"}, {"start": 142, "end": 176, "label": "HPO_TERM"}, {"start": 207, "end": 211, "label": "GENE_VARIANT"}]}
{"text": "Patient Z186 was evaluated for abnormally high AST levels. The patient also presented with a partial deficiency of complex I and complex I deficiency. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 146, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "Patient Z187 was evaluated for increased CSF lactate. The patient also presented with slowness of movement and a decrease in mitochondrial DNA in the muscles. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 52, "label": "HPO_TERM"}, {"start": 86, "end": 105, "label": "HPO_TERM"}, {"start": 110, "end": 157, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z188, who has a history of deficient cytochrome c oxidase activity. Examination also revealed an elevated CSF lactate level. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 95, "label": "HPO_TERM"}, {"start": 123, "end": 148, "label": "HPO_TERM"}, {"start": 203, "end": 207, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z189 includes bradykinesia and high AST levels. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 78, "label": "HPO_TERM"}, {"start": 104, "end": 108, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z190 were slowness of movement and an abnormal thalamic MRI signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 98, "label": "HPO_TERM"}, {"start": 124, "end": 128, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z191, who has a history of slowness of movement. Examination also revealed high levels of alanine aminotransferase. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 143, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z192, who has a history of an accumulation of multiple mtDNA deletions. Examination also revealed a decrease in mitochondrial DNA in the muscles. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 98, "label": "HPO_TERM"}, {"start": 126, "end": 173, "label": "HPO_TERM"}, {"start": 228, "end": 232, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z193, a patient with a partial deficiency of complex I. Further investigation showed a decrease in mitochondrial DNA in the muscles and a rise in AST concentration. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 82, "label": "HPO_TERM"}, {"start": 113, "end": 160, "label": "HPO_TERM"}, {"start": 165, "end": 191, "label": "HPO_TERM"}, {"start": 215, "end": 219, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z194 were a defect in mitochondrial complex I and cytochrome c oxidase deficiency. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 79, "label": "HPO_TERM"}, {"start": 84, "end": 114, "label": "HPO_TERM"}, {"start": 140, "end": 144, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z195, who has a history of a decrease in mitochondrial DNA in the muscles. Examination also revealed a reduction in complex I activity. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 104, "label": "HPO_TERM"}, {"start": 132, "end": 165, "label": "HPO_TERM"}, {"start": 220, "end": 224, "label": "GENE_VARIANT"}]}
{"text": "Patient Z196 was evaluated for abnormally high AST levels. The patient also presented with increased CSF lactate and slowness in voluntary movement. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 110, "label": "HPO_TERM"}, {"start": 115, "end": 144, "label": "HPO_TERM"}, {"start": 175, "end": 179, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z197, a patient with a reduction in complex I activity. Further investigation showed deficient cytochrome c oxidase activity and restricted diffusion on cerebral MRI. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 82, "label": "HPO_TERM"}, {"start": 113, "end": 152, "label": "HPO_TERM"}, {"start": 157, "end": 193, "label": "HPO_TERM"}, {"start": 218, "end": 222, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z198, who has a history of elevated aspartate aminotransferase. Examination also revealed elevated alanine aminotransferase. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 92, "label": "HPO_TERM"}, {"start": 120, "end": 153, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z199, who has a history of complex I deficiency. Examination also revealed a reduction in complex I activity. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 137, "label": "HPO_TERM"}, {"start": 192, "end": 196, "label": "GENE_VARIANT"}]}